Department of Chemistry and Chemical Biology, Purdue School of Science, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, USA.
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1685-8. doi: 10.1016/j.bmcl.2010.01.033. Epub 2010 Jan 20.
High-throughput fluorescent intercalator displacement (HT-FID) was adapted to the semi-automated screening of a commercial compound library containing 60,000 molecules resulting in the discovery of cytotoxic DNA-targeted agents. Although commercial libraries are routinely screened in drug discovery efforts, the DNA binding potential of the compounds they contain has largely been overlooked. HT-FID led to the rapid identification of a number of compounds for which DNA binding properties were validated through demonstration of concentration-dependent DNA binding and increased thermal melting of A/T- or G/C-rich DNA sequences. Selected compounds were assayed further for cell proliferation inhibition in glioblastoma cells. Seven distinct compounds emerged from this screening procedure that represent structures unknown previously to be capable of targeting DNA leading to cell death. These agents may represent structures worthy of further modification to optimally explore their potential as cytotoxic anti-cancer agents. In addition, the general screening strategy described may find broader impact toward the rapid discovery of DNA targeted agents with biological activity.
高通量荧光嵌入剂置换(HT-FID)被改编为半自动化筛选含有 60000 种分子的商业化合物库,从而发现了细胞毒性的 DNA 靶向试剂。尽管商业文库在药物发现工作中经常被筛选,但它们所含化合物的 DNA 结合潜力在很大程度上被忽视了。HT-FID 迅速鉴定出了许多化合物,这些化合物的 DNA 结合特性通过证明浓度依赖性的 DNA 结合和富含 A/T 或 G/C 的 DNA 序列的热融解得到了验证。选择的化合物进一步在神经胶质瘤细胞中进行了细胞增殖抑制检测。从这个筛选过程中出现了七种不同的化合物,它们代表了以前未知的能够靶向 DNA 导致细胞死亡的结构。这些试剂可能代表着具有进一步修饰潜力的结构,以最佳地探索它们作为细胞毒性抗癌剂的潜力。此外,所描述的一般筛选策略可能会更广泛地发现具有生物活性的 DNA 靶向试剂。